TimeScale Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$10.5K Hold
119
﹤0.01% 357
2023
Q1
$9.59K Sell
119
-75
-39% -$6.11K ﹤0.01% 353
2022
Q4
$15.7K Hold
194
﹤0.01% 247
2022
Q3
$16K Buy
194
+75
+63% +$6.74K ﹤0.01% 246
2022
Q2
$11K Hold
119
﹤0.01% 275
2022
Q1
$13K Hold
119
﹤0.01% 274
2021
Q4
$12K Hold
119
﹤0.01% 289
2021
Q3
$15K Hold
119
﹤0.01% 267
2021
Q2
$15K Sell
119
-48
-29% -$6.03K ﹤0.01% 271
2021
Q1
$20K Buy
167
+48
+40% +$5.63K 0.01% 268
2020
Q4
$14K Sell
119
-163
-58% -$17.9K ﹤0.01% 255
2020
Q3
$29K Buy
282
+163
+137% +$16.4K 0.01% 192
2020
Q2
$11K Hold
119
﹤0.01% 280
2020
Q1
$10K Hold
119
﹤0.01% 268
2019
Q4
$13K Hold
119
﹤0.01% 335
2019
Q3
$13K Hold
119
﹤0.01% 326
2019
Q2
$12K Buy
+119
New +$10.9K ﹤0.01% 344

Other funds holding MDT

TimeScale Financial's MDT Position: Q2 2023 in Review

TimeScale Financial held its Medtronic (MDT) position steady in Q2 2023 at 119 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

TimeScale Financial first reported a position in MDT in Q2 2019 and has held it in 17 quarters since. The position peaked at $29K in Q3 2020. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • TimeScale Financial held 119 shares of Medtronic worth $10.5K as of Q2 2023.
  • TimeScale Financial left its Medtronic share count unchanged in Q2 2023.
  • Medtronic made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #357 holding.
  • TimeScale Financial first reported a position in Medtronic in Q2 2019 and has held it in 17 quarters since.
  • TimeScale Financial's Medtronic position peaked at $29K in Q3 2020.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.